<DOC>
	<DOCNO>NCT02173275</DOCNO>
	<brief_summary>The study seek determine accuracy use anatomic physiologic information measurable compute tomography feature stenosis , plaque , fractional flow reserve-CT compare measure stress test detection myocardial ischemia gold standard cardiac catheterization fractional flow reserve . The hypothesis proposal integrate anatomic plaque feature physiologic fractional flow reserve-CT optimize identification coronary lesion ischemia-causing computed tomography .</brief_summary>
	<brief_title>Computed TomogRaphic Evaluation Atherosclerotic DEtermiNants Myocardial IsChEmia</brief_title>
	<detailed_description>The CREDENCE trial prospective multicenter cross-sectional study 618 individual ( n=309 [ derivation cohort ] ; n=309 [ validation cohort ] ) undergo stress test , compute tomography , cardiac catheterization fractional flow reserve . For purpose study , either stress test compute tomography perform clinical purpose , test perform part trial procedure . Study analyse focus diagnostic performance information derive stress test versus compute tomography invasive gold standard cardiac catheterization fractional flow reserve endpoint vessel territory-specific ischemia . In keep prior study , vessel territory comprise leave anterior descend artery ( diagonal branch ) , leave circumflex artery ( obtuse marginal branch ) right coronary artery ( posterolateral branch posterior descend artery ) . To date , relative performance traditional stress image test compare entirety information proffer CT assess compare unbiased gold standard . The study propose herein directly address unmet need .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<criteria>1 . Age &gt; 18 year 2 . Scheduled undergo clinicallyindicated nonemergent invasive coronary angiography 1 . Known CAD ( myocardial infarction [ MI ] , percutaneous coronary intervention [ PCIs ] , coronary artery bypass graft [ CABG ] , ) 2 . Hemodynamic instability 3 . Inability provide write informed consent 4 . Concomitant participation another clinical trial subject subject investigational drug device 5 . Pregnant state 6 . Absolute contraindication iodinate contrast due prior nearfatal anaphylactoid reaction ( laryngospasm , bronchospasm , cardiorespiratory collapse , equivalent ) 7 . Serum creatinine ≥1.7 mg/dl Glomerular Filtration Rate &lt; 30 ml/min 8 . Baseline irregular heart rhythm ( e.g. , atrial fibrillation , etc . ) 9 . Heart rate ≥100 beat per minute 10 . Systolic blood pressure ≤90 mm Hg 11 . Contraindications β blocker nitroglycerin adenosine 12 . BMI &gt; 40 kg/m2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>